← Back to Search

Aspiration Catheter

Aspiration Catheter for Stroke

N/A
Waitlist Available
Research Sponsored by Ministry of Science and Technology of the People´s Republic of China
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This study is a prospective, multi-center, open-label, end-point blinded, randomized, parallel positive control, non-inferiority clinical trial, with a purpose to evaluate the safety and efficacy of Hemo Jirui intracranial thrombus aspiration catheter system for endovascular treatment of acute ischemic stroke by comparison with stent retriever (Solitaire FR). The trial is anticipated to last from November 2018 to May 2019, with 204 subjects recruited from 15-20 clinical trial centers in China.

Eligible Conditions
  • Stroke

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Aspiration CatheterExperimental Treatment1 Intervention
Mechanical thrombectomy with Aspiration Catheter.
Group II: Stent Retriever (Solitaire FR)Active Control1 Intervention
Mechanical thrombectomy with Solitaire FR.

Find a Location

Who is running the clinical trial?

Ministry of Science and Technology of the People´s Republic of ChinaLead Sponsor
67 Previous Clinical Trials
528,268 Total Patients Enrolled
13 Trials studying Stroke
340,498 Patients Enrolled for Stroke
~30 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top